Search Results for NS0-004 Valid Learning Materials 🥌 Latest NS0-004 Exam Objectives ◀ Valid NS0-004 Exam Guide 🤸 Search for ▛ NS0-004 ▟ and easily obtain a free download on 「 www.pdfvce.com 」 🪓Latest NS0-004 Test Guide

The LEO Foundation Award 2024 – Region Americas

Grantee: Shruti Naik, Associate Professor, Icahn School of Medicine, Mount Sinai

Amount: USD 100,000

Grant category: LEO Foundation Awards

Year: 2024

Geography: USA

Dr. Shruti Naik is Associate Professor at the Ronald O Perelman Department of Dermatology, NYU Langone Health, in the US.

She receives the award in recognition of her exceptional scientific achievements, clear long-term career objectives, and innovative vision for skin research – which delves into the complex interactions between immune cells, surrounding skin cells, and skin-dwelling microbes to understand the origins and progression of skin diseases.

Read more

Mapping psoriasis around the World

…Director of the Global Psoriasis Atlas. The Global Psoriasis Atlas’ mission is to provide the common benchmark on the complete burden of psoriasis in all countries and regions throughout the…

400 million to LEO Foundation Skin Immunology Research Center

…best international research in skin, skin diseases and immunology. The new LEO Foundation Skin Immunology Research Center at the University of Copenhagen shall pave the way for better understanding, prevention…

SID Future Leaders Retreat

Grantee: Society for Investigative Dermatology

Amount: EUR 25,000

Grant category: Research Networking

Year: 2024

Geography: USA

The Future Leaders Retreat (previously known as Resident and Post Doc Retreat) is a conference hosted by the Society for Investigative Dermatology (SID) each year since 2001. The program format provides a protected space in which residents can interact with senior faculty and established investigators for the purpose of fostering attendee’s interest in academic research careers. The program is a combination of formal lectures and presentation, informal discussions, brainstorming sessions and social activities. The Retreat is held at the time of the SID annual meeting, which allows attendees to establish connections with each other, and to other meeting attendees. These social networks foster collegiality, collaborations, an appreciation for the creative, multidisciplinary nature of science and other productive interactions. Sustained exposure to the entire spectrum of dermatologic research will influence the trainees as they make their career decision, as well as build their enthusiasm for this area of science.

More information: https://www.sidannualmeeting.org/

Genetic mechanisms of acne vulgaris

Grantee: Michael Simpson, Professor of Genetics, King's College London

Amount: DKK 2,870,799

Grant category: Research Grants in open competition

Year: 2022

Geography: United Kingdom

The aim of Michael Simpson’s project is to identify potential cellular or molecular targets for acne treatment, based on analysis of genetic variation found in a large pool of acne patients.

Acne vulgaris is a very common skin disease which is characterized by clogging and inflammation of the pilosebaceous unit, which consists of a sweat gland and a hair follicle including the hair itself. While various potential causes leading to the disease have been investigated over the years, the underlying disease mechanisms have not yet been sufficiently elucidated. One common approach to learning more about cellular and molecular causes for development of disease in some people is to investigate changes in the genes that influence the behavior and communication paths of cells – the signaling cascades known to be involved in the disease. Michael and his team have previously identified several areas (loci) in the human genome which are associated with acne.

They now want to study these areas in further detail to better understand the causal molecular and cellular events that lead to acne and hopefully identify targets for treatment. They will use a three-step approach. Firstly, by identifying the genetic variants linked to the disease by analyzing genetic data from more than 60,000 individuals with acne. Secondly, they will cross-link these variations to create a map of the signaling pathways and associated cells responsible. Finally, based on this mapping, they expect to be able to identify targets for future treatments of the disease. If successful, the results may provide the first steps towards a better and more targeted treatment for this very common and socially stigmatizing skin disease.

The SIC Springtime School 2023-2028

Grantee: University of Copenhagen

Amount: DKK 4,300,000

Grant category: Standalone grants

Year: 2022

Geography: Denmark

SIC Springtime School is hosted annually by the LEO Foundation Skim Immunology Research Center (SIC) and has shown to be a great success over the two previous years. The international school is held at Hornbækhus on the North Coast of Zealand and forms part of SIC’s educational and career development activities – in 2022 representing 86 speakers, international students, and postdoc participants.  

The SIC Springtime School offers participants the opportunity to interact with leading scientists, providing for rich and positive learning experiences.  

More information

Phage therapy to treat group A Streptococcus in Necrotizing Soft Tissue Infection

Grantee: Thomas Sicheritz-Pontén, Professor, University of Copenhagen

Amount: DKK 3,988,469

Grant category: Research Grants in open competition

Year: 2023

Geography: Denmark

The project led by Thomas Sicheritz-Pontén from the Globe Institute at the University of Copenhagen, aims to carry out the fundamental work needed to develop targeted phage therapy (using bacteria-infecting viruses) to counter Necrotizing Soft Tissue Infections (NSTI).  This innovative treatment approach necessitates an in-depth understanding of the causative organisms, which will be achieved through sequencing these organisms and employing machine learning algorithms to predict their susceptibility to specific phages.

Necrotizing Soft Tissue Infections (NSTI), also known as “flesh-eating disease”, are rapidly escalating globally, posing a deadly bacterial threat that necessitates innovative therapeutic strategies due to its profound impact on human health. NSTI is characterized by aggressive skin manifestations primarily caused by Group A Streptococcus (Strep A). Although prompt surgery and antibiotics serve as the first-line treatment, infections often progress to necrosis, rendering antibiotics ineffective and often necessitating amputation and in worst case death.

Bacteriophages, or simply phages, offer a promising avenue to address this severe skin and soft tissue infection. Phages are viruses that selectively infect and eliminate bacteria, including antibiotic-resistant strains, without harming human cells.

Thomas Sicheritz-Pontén and team will do the fundamental work needed to identify prototype tailored phage therapies targeting Strep A. Along with his team, comprised of chief physicians from three different Danish hospitals, the UK Centre for Phage Research and the University of Copenhagen, Thomas Sicheritz-Pontén intends to identify phages capable of rapidly eradicating the bacteria, harness bacterial enzymes (endolysins), and employ phage satellites (mobile genetic elements that parasitize phages) for gene delivery.

By collaborating across research hubs, the team will decode Strep A’s genetic makeup, thereby facilitating the creation of precise phage cocktails and develop a novel molecular typing system to predict bacterial susceptibility, streamlining targeted phage treatments.

If successful, Thomas Sicheritz-Pontén’s project may greatly aid the battle against deadly NSTI infections through innovative development of phage therapy.

Striving to develop and implement culturally sensitive dermatologic care with the focus on eczema and psoriasis in the Cree Territory of James Bay (Eeyou Istchee)

Grantee: Ivan Litvinov, Associate Professor, McGill University Health Centre

Amount: DKK 3,074,290

Grant category: Research Grants in open competition

Year: 2023

Geography: Canada

Ivan Litvinov’s project aims to co-create with Indigenous partners and implement a culturally sensitive dermatological care system in the Cree territories in Quebec, one of Canada’s First Nations. Dermatologic care for Canadian Indigenous populations is severely lacking currently. While many safe advanced treatments are available for debilitating diseases, including atopic dermatitis that affects ~15-20% of First Nations in Quebec, these treatments are not accessible in the Northern remote regions due to a lack of established care.

Ivan Litvinov’s proposed implementation science project will be centered on meaningful engagement of patients, health care providers (HCPs) and wider communities, continuous monitoring, analysis, and feedback based on collected data to the members of the steering committee and to the Cree Health Board/Elders overseeing the effort with the goal of achieving the Quintuple Aim (improved patient experience, better outcomes, lower costs, clinician well-being and health equity) for the region.

Ivan Litvinov’s project will leverage the existing RUISSS (Réseau Universitaire Intégré de Santé et de Services Sociaux) infrastructure to establish in-person care in 3 key Cree communities and will 1) establish a Learning Healthcare System (LHS); 2) collect quantitative and qualitative data on skin diseases, barriers and treatments; 3) recruit and support healthcare professionals to the region to foster a community of practice and promote a community of concern amongst patients through Patient and Public Involvement, knowledge mobilization and educational activities.

The impact of the project will be a co-creation of a culturally sensitive sustainable dermatologic care in the region. Results of this work will be shared with other specialties working in the region, other First Nation communities in Quebec in Canada and in other countries (e.g., Greenland).

Center for Pharmaceutical Data Science Education

Grantee: The University of Copenhagen and the University of Southern Denmark

Amount: DKK 30,000,000

Grant category: Standalone grants

Year: 2024

Geography: Denmark

Center for Pharmaceutical Data Science Education is funded by the LEO Foundation, the Novo Nordisk Foundation and the Lundbeck Foundation with a total of DKK 123 million over a six-year period.

The new center merges two fields of study – the pharmaceutical sciences and data science – and will ensure the students’ qualifications in data science by upgrading relevant compulsory bachelor’s and master’s courses. Artificial intelligence, machine learning and the use of big data open a huge area of knowledge, new data sources and methods, which should be integrated in the best possible way in the pharmaceutical sciences education.

New funding to future-proof pharmaceutical sciences education

and data science – and will ensure the students’ qualifications in data science by upgrading relevant compulsory bachelor’s and master’s courses. Artificial intelligence, machine learning and the use of big…